Carbohydrate/peptide mimics: Effect on MUC1 cancer immunotherapy

Journal of Molecular Medicine

Volumn 77, Issue 5, 1999, Pages 427-436

  Apostolopoulos, V ^a   Sandrin, M S ^a   McKenzie, I F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Galactose (l,3)galactose; Immune deviation; Immunotherapy; Mimics; MUC1

Indexed keywords

CARBOHYDRATE; CYTOKINE; GALACTOSE; MANNAN; MUCIN; MUCIN 1 PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; REVIEW; XENOTRANSPLANTATION;

ANIMALS; CA-15-3 ANTIGEN; CARBOHYDRATES; CROSS REACTIONS; DISACCHARIDES; HUMANS; IMMUNOTHERAPY; MANNANS; MICE; MOLECULAR MIMICRY; NEOPLASMS; PEPTIDES;

EID: 0032968911     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050373     Document Type: Review

References (57)

1. 1. Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705
2. 2. Davies JM (1997) Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 75:113-126
3. 3. Durinovic-Bello I (1998) Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens. Autoimmunity 27: 159-177
4. 4. Murali R, Kieber-Emmons T (1997) Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody. J Mol Recognit 10:269-276
5. 5. Apostolopoulos V, Lofthouse SA, Popovski V, Chelvanayagam G, Sandrin MS, McKenzie IFC (1998) Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol 16:276-280
6. 6. Apostolopoulos V, Pietersz GA, McKenzie IFC (1996) Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine 14:930-938
7. 7. Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IFC (1995) Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci USA 92:10128-10132
8. 8. Karanikas V, Hwang L, Pearson J, Ong CS, Apostolopoulos V, Vaughan H, Xing PX, Jamieson G, Pietersz GA, Tait B, Broadbent R, Thynne G, McKenzie IFC (1997) Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest 100:2783-2792
9. 9. Apostolopoulos V, Osinski C, McKenzie IFC (1998) MUC1 cross reactive Galα(1,3)Gal Abs in humans switch immune responses from cellular to humoral. Nat Med 4:315-320
10. 10. Vaughan HA, Loveland BE, Sandrin MS (1994) Galα(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic antibodies. Transplantation 58:879-884
11. 11. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC (1995) Anti-pig anitibodies in human serum predominantly react with Galα(1,3)Gal epitopes. Proc Natl Acad Sci USA 90:11391-11395
12. 12. Vaughan HA, Oldenburg KR, Gallop MA, Atkin JD, McKenzie IFC, Sandrin MS (1996) Recognition of an octapeptide sequence by multiple Galα(1,3)Gal-binding proteins. Xenotrans-plantation 3:18-23
13. 13. Sandrin MS, Vaughan HA, Xing PX, McKenzie IFC (1997) Natural human anti-Galα(1,3)Gal antibodies react with human mucin peptides. Glycoconj J 14:97-105
14. 14. Oldenburg KR, Loganathan D, Goldstein IJ, Schultz PG, Gallop MA (1992) Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc Natl Acad Sci USA 89:5393-5397
15. 15. Scott JK, Loganathan D, Easley RB, Gong X, Goldstein IJ (1992) A family of concanavilin A-binding peptides from a hexapeptide epitope library. Proc Natl Acad Sci USA 89: 5398-5402
16. 16. Hoess R, Brinkmann U, Handel T, Pastan I (1993) Identification of a peptide which binds to the carbohdrate-specific monoclonal antibody B3. Gene 128:43-49
17. 17. Kieber-Emmons T, Luo P, Qiu J, Agadjanyan M, Carey L, Hutchins W, Westerink MA, Steplewski Z (1997) Peptide mimicry of adenocarcinoma-associated carbohydrate antigens. Hybridoma 16:3-10
18. 18. Agadjanyan M, Luo P, Westerink MA, Carey LA, Hutchins W, Steplewski Z, Weiner DB, Kieber-Emmons T (1997) Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat Biotechnol 15:547-551
19. 19. Harris SL, Craig L, Mehroke JS, Rashed M, Zwick MB, Kenar K, Toone EJ, Greenspan N, Auzanneau F-I, Marino-Albernas J-R, Pinto BM, Scott JK (1997) Exploring the basis of peptide-carbohydrate cross reactivity: evidence for discrimination by peptides betwen closely related anti-carbohydrate antibodies. Proc Natl Acad Sci USA 94:2454-2459
20. 20. Pincus SH, Smith MJ, Jenning HJ, Burrit JB, Glee PM (1998) Peptides that mimic the group B Streptococcal Type III capsular polysaccharide antigen. J Immunol 160:293-298
21. 21. Valadon P, Nussbaum G, Boyd LF, Margulies DH, Scharaff MD (1996) Peptide libraries define fine structure of anti-polysaccharide antibodies to Cryptococcus neoformans. J Mol Biol 261:11-22
22. 22. Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F (1997) Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol 27:2620-2625
23. 23. Taki T, Ishikawa D, Hamasaki H, Handa S (1997) Preparation of peptides which mimic glycosphingolipids by using phage peptide library and their modulation on b-galactosidase activity. FEBS Lett 418:219-223
24. 24. Saleh MN, Stapleton JD, Khazaeli MB, LoBuglio AF (1993) Generation of a human anti-idiotypic antibody that mimics the GD2 antigen. J Immunol 151:3390-3398
25. 25. Westerink MA, Apicella MA (1993) Anti-idiotypic antibodies as vaccines against carbohydrate antigens. Springer Semin Immunopathol 15:227-234
26. 26. Westerink M A. J, Giardina PC, Apicella MA, Keiber-Emmons T (1995) Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci USA 92:4021-4025
27. 27. Shikhman AR, Greenspan NS, Curmingham MW (1993) A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A Streptococcal M proteins recognozes N-acetyl-b-D-glucosamine. J Immunol 151:3902-3913
28. 28. Shikhman AR, Greenspan NS, Cunningham MW (1994) Cytokeratin peptide SFGSGFGGY mimics N-acetyl-b-D-glucosamie in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. J Immunol 153:5593-5606
29. 29. Xing PX, Tjandra JJ, Stacker SA, Teh JG, Thompson CH, McLaughlin PJ, McKenzie IFC (1989) Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol 67:183-195
30. 30. Lofthouse SA, Apostolopoulos V, Pietersz GA, McKenzie IFC (1997) Induction of T1 (CTL) and/or T2 (antibody) response to amucin-1 tumor antigen. Vaccine 15:1586-1593
31. 31. Apostolopoulos V, Haurum JS, McKenzie IFC (1997) MUC1 peptide epitopes associated with 5 different H2 class I molecules. Eur J Immunol 27:2579-2587
32. 32. Apostolopoulos V, Karanikas V, Haurum J, McKenzie IFC (1997) Induction of HLA-A2 restricted cytotoxic T lymphocytes to the MUC1 human breast cancer antigen. J Immunol 159:5211-5218
33. 33. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted pro teins. J Immunol 136:2348-2357
34. 34. Coffman RL, Varkila K, Scott P, Chatelain R (1991) Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 123:189-207
35. 35. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282
36. 36. Kelso A, Gough NM (1998) Coexpression of granulocytemacrophage colony stimulating factor, gamma interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones. Proc Natl Acad Sci USA 85:9189-9193
37. 37. Paliard X, de Waal Malefrjt R, Yssel H, Blanchard D, Chretien I, Abrams J, de Vries J, Spits H (1988) Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol 14:849-855
38. 38. Parish CR (1971) Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J Exp Med 13:21-47
39. 39. Urban JF Jr, Madden KB, Svetic A, Cheever A, Trotta PP, Gause WC, Katona IM, Finkelman FD (1992) The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 127:205-220
40. 40. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
41. 41. Parish CR (1972) The relationship between humoral and cell-mediated immunity. Transpl Rev 13:35-66
42. 42. Mitchison NA (1964) Induction of immunological paralysis in two zones of dosages. Proc R Soc Lond B Biol Med 161:275-292
43. 43. Pietersz GA, Li W, Popovski V, Caruana JA, Apostolopoulos V, McKenzie IFC (1998) Parameters for using mannan-MUC1 fusion protein to induce cellular immunity. Cancer Immunol Immunother 45:321-326
44. 44. Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IFC (1995) Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci USA 92:10128-10132
45. 45. Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA (1988) Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 263:17733-17762
46. 46. Joziasse DH, Shaper JH, Jabs EW, ShaperNC (1991) Characterization of an alpha 1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem 266:6991-6998
47. 47. Larsen RD, Rivera-Marrero CA, Ernst LK, Cummings RD, Lowe JB. Frameshift, nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA (1990) J Biol Chem 265:7055-7061
48. 48. Galili U, La Temple C (1997) Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity. Immunol Today 18:281-285
49. 49. Henion TR, Gerhard W, Anaraki F, Galili U (1997) Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3 galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody. Vaccine 15:1174-1182
50. 50. Celis E, Abraham KG, Miller RW (1987) Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology 7:563-568
51. 51. Bouige P, Iscaki S, Cosson A, Pillot J (1996) Molecular analysis of the modulatory factors of the response to HBsAg in mice as an approach to HBV vaccine enhancement. Immunol MedMicrobiol 13:71-79
52. 52. Galili U, Repik PM, Anaraki F, Mozdzanowska K, Washko G, Gerhard W (1996) Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody. Vaccine 14:321-328
53. 53. Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T (1998) B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 4:627-630
54. 54. Apostolopoulos V, Chelvanayagam G, Xing PX, McKenzie IFC (1998) Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules. J Immunol 161:767-775
55. 55. Gong J, Chen L, Chen D, Kashiwaba M, Manome Y, Tanaka T, Kufe D (1997) Induction of antigen-specific antitumor immunity with adeno virus-transduced dendritic cells. Gene Ther 4:1023-1028
56. 56. Akagi J, Nakagawa K, Egami H, Ogawa M (1998) Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-1 vaccinia virus. Cancer Immunol Immunother 47:21-31
57. 57. Reddish M, MacLean GD, Koganty RR, Kan-Mitchell J, Jones V, Mitchell MS, Longenecker BM (1998) Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int J Cancer 76:817-823